Dynavax (NASDAQ: DVAX) reported Q1 EPS of ($0.62), $0.03 better than the analyst estimate of ($0.65). Revenue for the quarter came in at $5.6 million versus the consensus estimate of $5.6 million.

For earnings history and earnings-related data on Dynavax (DVAX) click here.